200
Participants
Start Date
March 1, 2022
Primary Completion Date
February 28, 2026
Study Completion Date
February 28, 2031
Metformin ER
Oral medication typically used for Type 2 diabetes with presumed anti-inflammatory properties
placebo
Matched to active study drug
RECRUITING
VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA, Pittsburgh
University of Pittsburgh
OTHER
Northwestern University
OTHER
San Francisco Veterans Affairs Medical Center
FED
VA Office of Research and Development
FED